Magnesium in chronic kidney disease: Challenges and opportunities

Blood Purification

Volumn 29, Issue 3, 2010, Pages 280-292

  Kanbay, Mehmet ^a   Goldsmith, David ^c   Uyar, Mehtap Erkmen ^b   Turgut, Faruk ^a   Covic, Adrian ^d  

^a Section of Nephrology   (United States)

^b FATIH UNIVERSITY   (Turkey)

^c GUY S HOSPITAL   (United Kingdom)

^d C I PARHON NATIONAL INSTITUTE OF ENDOCRINOLOGY   (Romania)

Author keywords

Cardiovascular disease; Chronic kidney disease; Magnesium; Renal transplantation

Indexed keywords

CYCLOSPORIN A; MAGNESIUM; NITRIC OXIDE SYNTHASE; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; TACROLIMUS; VITAMIN D;

ARTERIAL WALL THICKNESS; ARTERIOSCLEROSIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; GRAFT RECIPIENT; HEMODIALYSIS PATIENT; HOMEOSTASIS; HUMAN; HYPERMAGNESEMIA; HYPERPARATHYROIDISM; HYPERTENSION; HYPOMAGNESEMIA; KIDNEY TRANSPLANTATION; MAGNESIUM BLOOD LEVEL; NEPHROTOXICITY; NONHUMAN; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; REVIEW; THROMBOSIS;

ARTERIOSCLEROSIS; ATHEROSCLEROSIS; CALCINOSIS; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; HUMANS; IMMUNOSUPPRESSION; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MAGNESIUM; PARATHYROID HORMONE; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; TUNICA INTIMA; TUNICA MEDIA;

EID: 74249117589     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000276665     Document Type: Review

References (101)

1. Altura BM, Altura BT: New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. I. Clinical aspects. Magnesium 1985; 4: 226-244.
2. Shechter M, Merz CN, Paul-Labrador M, Meisel SR, Rude RK, Molloy MD, et al: Oral magnesium supplementation inhibits platelet- dependent thrombosis in patients with coronary artery disease. Am J Cardiol 1999; 84: 152-156.
3. Malpuech-Brugere C, Nowacki W, Daveau M, Gueux E, Linard C, Rock E, et al: Inflammatory response following acute magnesium deficiency in the rat. Biochim Biophys Acta 2000; 1501: 91-98.
4. Malpuech-Brugere C, Nowacki W, Rock E, Gueux E, Mazur A, Rayssiguier Y: Enhanced tumor necrosis factor-alpha production following endotoxin challenge in rats is an early event during magnesium deficiency. Biochim Biophys Acta 1999; 1453: 35-40.
5. Baxter GF, Sumeray MS, Walker JM: Infarct size and magnesium: insights into LIMIT-2 and ISIS-4 from experimental studies. Lancet 1996; 348: 1424-1426.
6. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, et al: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483.
7. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in endstage renal disease. Hypertension 2001; 38: 938-942.
8. Turgut F, Kanbay M, Metin MR, Uz E, Akcay A, Covic A: Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int Urol Nephrol 2008.
9. Tzanakis I, Virvidakis K, Tsomi A, Mantakas E, Girousis N, Karefyllakis N, et al: Intraand extracellular magnesium levels and atheromatosis in haemodialysis patients. Magnes Res 2004; 17: 102-108.
10. Ganesh SK, Stack AG, Levin NW, Hulbert- Shearon T, Port FK: Association of elevated serum PO(4), Ca ! PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001; 12: 2131-2138.
11. Wolf FI, Cittadini A: Magnesium in cell proliferation and differentiation. Front Biosci 1999; 4:D607-D617.
12. Fox C, Ramsoomair D, Carter C: Magnesium: its proven and potential clinical significance. South Med J 2001; 94: 1195-1201.
13. Moe SM: Disorders of calcium, phosphorus, and magnesium. Am J Kidney Dis 2005; 45: 213-218.
14. Walder RY, Landau D, Meyer P, Shalev H, Tsolia M, Borochowitz Z, et al: Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat Genet 2002; 31: 171-174.
15. Altura BM, Altura BT (eds): Role of Magnesium in the Pathogenesis of Hypertension: Relationship of Its Actions on Cardiac, Vascular Smooth Muscle and Endothelial Cells. New York, Raven Press, 1995.
16. Navarro-González JF, Mora-Fernández C, García- Pérez J: Clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysis. Semin Dial 2009; 22: 37-44.
17. Martin KJ, González EA, Gellens ME, Hamm LL, Abboud H, Lindberg J: Therapy of secondary hyperparathyroidism with 19- nor-1alpha,25- dihydroxyvitamin D2. Am J Kidney Dis 1998; 32(2 suppl 2):S61-S66.
18. Contiguglia SR, Alfrey AC, Miller N, Butkus D: Total-body magnesium excess in chronic renal failure. Lancet 1972; 1: 1300-1302.
19. Schmulen AC, Lerman M, Pak CY, Zerwekh J, Morawski S, Fordtran JS, Vergne-Marini P: Effect of 1,25-(OH)2D3 on jejunal absorption of magnesium in patients with chronic renal disease. Am J Physiol 1980; 238:G349-G352.
20. Krejs GJ, Nicar MJ, Zerwekh JE, Norman DA, Kane MG, Pak CY: Effect of 1,25-dihydroxyvitamin D3 on calcium and magnesium absorption in the healthy human jejunum and ileum. Am J Med 1983; 75: 973-976.
21. Mountokalakis TD: Magnesium metabolism in chronic renal failure. Magnes Res 1990; 3: 121-127.
22. Navarro JF, Macia ML, Gallego E, Mendez ML, Chahin J, Garcia-Nieto V, et al: Serum magnesium concentration and PTH levels. Is long-term chronic hypermagnesemia a risk factor for adynamic bone disease? Scand J Urol Nephrol 1997; 31: 275-280.
23. Brown EM: Extracellular Ca 2+ sensing, regulation of parathyroid cell function, and role of Ca 2+ and other ions as extracellular (first) messengers. Physiol Rev 1991; 71: 371-411.
24. Ferment O, Garnier PE, Touitou Y: Comparison of the feedback effect of magnesium and calcium on parathyroid hormone secretion in man. J Endocrinol 1987; 113: 117-122.
25. Cholst IN, Steinberg SF, Tropper PJ, Fox HE, Segre GV, Bilezikian JP: The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects. N Engl J Med 1984; 310: 1221-1225.
26. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC: Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996; 27: 394-401.
27. Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium ! phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998; 31: 607-617.
28. Liao F, Folsom AR, Brancati FL: Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 1998; 136: 480-490.
29. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, et al: Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol 1995; 48: 927-940.
30. Peacock JM, Folsom AR, Arnett DK, Eckfeldt JH, Szklo M: Relationship of serum and dietary magnesium to incident hypertension: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 1999; 9: 159-165.
31. Abbott RD, Ando F, Masaki KH, Tung KH, Rodriguez BL, Petrovitch H, et al: Dietary magnesium intake and the future risk of coronary heart disease (the Honolulu Heart Program). Am J Cardiol 2003; 92: 665-669.
32. Shechter M, Sharir M, Labrador MJ, Forrester J, Silver B, Bairey Merz CN: Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation 2000; 102: 2353-2358.
33. Rasmussen HS, Aurup P, Goldstein K, Mc- Nair P, Mortensen PB, Larsen OG, et al: Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease. A double-blind, placebo controlled study. Arch Intern Med 1989; 149: 1050-1053.
34. Ravn HB, Moeldrup U, Brookes CI, Ilkjaer LB, White P, Chew M, et al: Intravenous magnesium reduces infarct size after ischemia/ reperfusion injury combined with a thrombogenic lesion in the left anterior descending artery. Arterioscler Thromb Vasc Biol 1999; 19: 569-574.
35. Zheng D, Upton RN, Ludbrook GL, Martinez A: Acute cardiovascular effects of magnesium and their relationship to systemic and myocardial magnesium concentrations after short infusion in awake sheep. J Pharmacol Exp Ther 2001; 297: 1176-1183.
36. Schneiderman J, Sawdey MS, Keeton MR, Bordin GM, Bernstein EF, Dilley RB, et al: Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci USA 1992; 89: 6998-7002.
37. Mazur A, Maier JA, Rock E, Gueux E, Nowacki W, Rayssiguier Y: Magnesium and the inflammatory response: potential physiopathological implications. Arch Biochem Biophys 2007; 458: 48-56.
38. Maier JA, Bernardini D, Rayssiguier Y, Mazur A: High concentrations of magnesium modulate vascular endothelial cell behaviour in vitro. Biochim Biophys Acta 2004; 1689: 6-12.
39. Kontani M, Hara A, Ohta S, Ikeda T: Hypermagnesemia induced by massive cathartic ingestion in an elderly woman without preexisting renal dysfunction. Intern Med 2005; 44: 448-452.
40. Navarro-González JF, Mora-Fernández C, García- Pérez J: Clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysis. Semin Dial 2009; 22: 37-44.
41. Bourgeois FJ, Thaigarajah S, Harbert GM, DiFazio C: Profound hypotension complicating magnesium therapy. Am J Obstet Gynecol 1986; 154: 919-920.
42. Fassler CA, Rodriguez RM, Badesch DB, Stone WJ, Marini JJ: Magnesium toxicity as a cause of hypotension and hypoventilation. Arch Intern Med 1985; 145: 1604-1606.
43. Rude RK, Singer FR: Magnesium deficiency and excess. Annu Rev Med 1981; 32: 245-259.
44. Sánchez C, López-Barea F, Sánchez-Cabezudo J, Bajo A, Mate A, Martínez E, et al: Low versus standard calcium dialysate in peritoneal dialysis: differences in treatment, biochemistry and bone histomorphometry. A randomized multicentre study. Nephrol Dial Transplant 2004; 19: 1587-1593.
45. Bro S, Brandi L, Olgaard K: Risk/benefit in prophylaxis and treatment of secondary hyperparathyroidism. A comparison of two low calcium peritoneal dialysis fluids. Nephrol Dial Transplant 1996; 11(suppl 3): 47-49.
46. Pletka P, Bernstein DS, Hampers CL, Merrill JP, Sherwood LM: Relationship between magnesium and secondary hyperparathyroidism during long-term hemodialysis. Metabolism 1974; 23: 619-630.
47. Parsons V, Papapoulos SE, Weston MJ, Tomlinson S, O'Riordan JL: The long-term effect of lowering dialysate magnesium on circulating parathyroid hormone in patients on regular haemodialysis therapy. Acta Endocrinol (Copenh) 1980; 93: 455-460.
48. Gonella M, Bonaguidi F, Buzzigoli G, Bartolini V, Mariani G: On the effect of magnesium on the PTH secretion in uremic patients on maintenance hemodialysis. Nephron 1981; 27: 40-42.
49. McGonigle RJ, Weston MJ, Keenan J, Jackson DB, Parsons V: Effect of hypermagnesemia on circulating plasma parathyroid hormone in patients on regular hemodialysis therapy. Magnesium 1984; 3: 1-7.
50. O'Donovan R, Baldwin D, Hammer M, Moniz C, Parsons V: Substitution of aluminium salts by magnesium salts in control of dialysis hyperphosphataemia. Lancet 1986; 1: 880-882.
51. Kenny MA, Casillas E, Ahmad S: Magnesium, calcium and PTH relationships in dialysis patients after magnesium repletion. Nephron 1987; 46: 199-205.
52. Oe PL, Lips P, van der Meulen J, de Vries PM, van Bronswijk H, Donker AJ: Long-term use of magnesium hydroxide as a phosphate binder in patients on hemodialysis. Clin Nephrol 1987; 28: 180-185.
53. Bellucci G, Alessandri M, Buracchi P, Caponetti R, Gabbrielli C, Massanti L, et al: Serum magnesium concentration and serum parathormone in hemodialysis patients. Italian Journal of Mineral and Electrolyte Metabolism 1998; 12: 77-79.
54. Navarro JF, Mora C, Jimenez A, Torres A, Macia M, Garcia J: Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients. Am J Kidney Dis 1999; 34: 43-48.
55. Gohda T, Shou I, Fukui M, Funabiki K, Horikoshi S, Shirato I, et al: Parathyroid hormone gene polymorphism and secondary hyperparathyroidism in hemodialysis patients. Am J Kidney Dis 2002; 39: 1255-1260.
56. Guh JY, Chen HC, Chuang HY, Huang SC, Chien LC, Lai YH: Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients. Am J Kidney Dis 2002; 39: 1245-1254.
57. Baradaran A, Nasri H: Correlation of serum magnesium with serum parathormone levels in patients on regular hemodialysis. Saudi J Kidney Dis Transpl 2006; 17: 344-350.
58. Saha HH, Harmoinen AP, Pasternack AI: Measurement of serum ionized magnesium in CAPD patients. Perit Dial Int 1997; 17: 347-352.
59. Navarro JF, Mora C, García J, Macía M, Gallego E, Chahin J, et al: Hypermagnesemia in CAPD. Relationship with parathyroid hormone levels. Perit Dial Int 1998; 18: 77-80.
60. Navarro JF, Mora C, Macia M, Garcia J: Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients. Perit Dial Int 1999; 19: 455-461.
61. Cho MS, Lee KS, Lee YK, Ma SK, Ko JH, Kim SW, et al: Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate. Korean J Intern Med 2002; 17: 114-121.
62. Katopodis KP, Koliousi EL, Andrikos EK, Pappas MV, Elisaf MS, Siamopoulos KC: Magnesium homeostasis in patients undergoing continuous ambulatory peritoneal dialysis: role of the dialysate magnesium concentration. Artif Organs 2003; 27: 853-857.
63. Takahashi S, Okada K, Yanai M: Magnesium and parathyroid hormone changes to magnesium- free dialysate in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1994; 14: 75-78.
64. Meema HE, Oreopoulos DG, Rapoport A: Serum magnesium level and arterial calcification in end-stage renal disease. Kidney Int 1987; 32: 388-394.
65. Ng AH, Hercz G, Kandel R, Grynpas MD: Association between fluoride, magnesium, aluminum and bone quality in renal osteodystrophy. Bone 2004; 34: 216-224.
66. Coburn JW, Popovtzer MM, Massry SG, Kleeman CR: The physicochemical state and renal handling of divalent ions in chronic renal failure. Arch Intern Med 1969; 124: 302-311.
67. Nilsson P, Johansson SG, Danielson BG: Magnesium studies in hemodialysis patients before and after treatment with low dialysate magnesium. Nephron 1984; 37: 25-29.
68. Gupta BK, Glicklich D, Tellis VA: Magnesium repletion therapy improved lipid metabolism in hypomagnesemic renal transplant recipients: a pilot study. Transplantation 1999; 67: 1485-1487.
69. Aisa Y, Mori T, Nakazato T, Shimizu T, Yamazaki R, Ikeda Y, et al: Effects of immunosuppressive agents on magnesium metabolism early after allogeneic hematopoietic stem cell transplantation. Transplantation 2005; 80: 1046-1050.
70. Navaneethan SD, Sankarasubbaiyan S, Gross MD, Jeevanantham V, Monk RD: Tacrolimus- associated hypomagnesemia in renal transplant recipients. Transplant Proc 2006; 38: 1320-1322.
71. Yuan J, Zhou J, Chen BC, Zhang X, Zhou HM, Du DF, et al: Magnesium supplementation prevents chronic cyclosporine nephrotoxicity via adjusting nitric oxide synthase activity. Transplant Proc 2005; 37: 1892-1895.
72. Holzmacher R, Kendziorski C, Michael Hofman R, Jaffery J, Becker B, Djamali A: Low serum magnesium is associated with decreased graft survival in patients with chronic cyclosporin nephrotoxicity. Nephrol Dial Transplant. 2005; 20: 1456-1462.
73. Collins AJ, Li S, Ma JZ, Herzog C: Cardiovascular disease in end-stage renal disease patients. Am J Kidney Dis 2001; 38(4 suppl 1): S26-S29.
74. Krasniak A, Drozdz M, Pasowicz M, Chmiel G, Michalek M, Szumilak D, et al: Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients. Nephrol Dial Transplant 2007; 22: 515-521.
75. Ishimura E, Okuno S, Kitatani K, Tsuchida T, Yamakawa T, Shioi A, et al: Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients. Clin Nephrol 2007; 68: 222-227.
76. Nakagawa K: A study of aortic calcification uremia (in Japanese). Nippon Jinzo Gakkai Shi 1997; 39: 135-143.
77. Drachman R, Baillet G, Gagnadoux MF, de Vernejoul P, Broyer M: Pulmonary calcifications in children on dialysis. Nephron 1986; 44: 46-50.
78. Tzanakis I, Pras A, Kounali D, Mamali V, Kartsonakis V, Mayopoulou-Symvoulidou D, et al: Mitral annular calcifications in haemodialysis patients: a possible protective role of magnesium. Nephrol Dial Transplant 1997; 12: 2036-2037.
79. Izawa H, Imura M, Kuroda M, Takeda R: Proceedings: effect of magnesium on secondary hyperparathyroidism in chronic hemodialysis: a case with soft tissue calcification improved by high Mg dialysate. Calcif Tissue Res 1974; 15: 162.
80. Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, et al: The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin- A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003; 112: 357-366.
81. Van den Broek FA, Beems RB, van Tintelen G, Lemmens AG, Fielmich-Bouwman AX, Beynen AC: Co-variance of chemically and histologically analysed severity of dystrophic cardiac calcification in mice. Lab Anim 1997; 31: 74-80.
82. Boskey AL, Posner AS: Effect of magnesium on lipid-induced calcification: an in vitro model for bone mineralization. Calcif Tissue Int 1980; 32: 139-143.
83. Altura BM, Altura BT, Gebrewold A, Ising H, Gunther T: Magnesium deficiency and hypertension: correlation between magnesium- deficient diets and microcirculatory changes in situ. Science 1984; 223: 1315-1317.
84. Mitsopoulos E, Griveas I, Zanos S, Anagnostopoulos K, Giannakou A, Pavlitou A, et al: Increase in serum magnesium level in haemodialysis patients receiving sevelamer hydrochloride. Int Urol Nephrol 2005; 37: 321-328.
85. Mazzaferro S, Coen G, Bandini S, Borgatti PP, Ciaccheri M, Diacinti D, et al: Role of ageing, chronic renal failure and dialysis in the calcification of mitral annulus. Nephrol Dial Transplant 1993; 8: 335-340.
86. Rostand SG, Sanders C, Kirk KA, Rutsky EA, Fraser RG: Myocardial calcification and cardiac dysfunction in chronic renal failure. Am J Med 1988; 85: 651-657.
87. Tzanakis I, Tsomi A, Mantakas E, Papadaki AN, Kallivretakis N: The higher intracellular magnesium, the better long-term survival on hemodialysis. 39th ASN Congress. San Diego, 2006.
88. Ishimura E, Okuno S, Yamakawa T, Inaba M, Nishizawa Y: Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients. Magnes Res 2007; 20: 237-244.
89. Laurant P, Touyz RM: Physiological and pathophysiological role of magnesium in the cardiovascular system: implications in hypertension. J Hypertens 2000; 18: 1177-1191.
90. Douban S, Brodsky MA, Whang DD, Whang R: Significance of magnesium in congestive heart failure. Am Heart J 1996; 132: 664-671.
91. Kyriazis J, Kalogeropoulou K, Bilirakis L, Smirnioudis N, Pikounis V, Stamatiadis D, Liolia E: Dialysate magnesium level and blood pressure. Kidney Int 2004; 66: 1221-1231.
92. Turlapaty PD, Altura BM: Magnesium deficiency produces spasms of coronary arteries: relationship to etiology of sudden death ischemic heart disease. Science 1980; 208: 198-200.
93. Altura BM, Gebrewold A, Altura BT, Brautbar N: Magnesium depletion impairs myocardial carbohydrate and lipid metabolism and cardiac bioenergetics and raises myocardial calcium content in-vivo: relationship to etiology of cardiac diseases. Biochem Mol Biol Int 1996; 40: 1183-1190.
94. Kharb S, Singh V: Magnesium deficiency potentiates free radical production associated with myocardial infarction. J Assoc Physicians India 2000; 48: 484-485.
95. Parsons V, Baldwin D, Moniz C, Marsden J, Ball E, Rifkin I: Successful control of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis using magnesium carbonate and calcium carbonate as phosphate binders. Nephron 1993; 63: 379-383.
96. Delmez JA, Kelber J, Norword KY, Giles KS, Slatopolsky E: Magnesium carbonate as a phosphorus binder: a prospective, controlled, crossover study. Kidney Int 1996; 49: 163-167.
97. Fine KD, Santa Ana CA, Porter JL, Fordtran JS: Intestinal absorption of magnesium from food and supplements. J Clin Invest 1991; 88: 396-402.
98. Spiegel DM, Farmer B, Smits G, Chonchol M: Magnesium carbonate is an effective phosphate binder for chronic hemodialysis patients: a pilot study. J Ren Nutr 2007; 17: 416-422.
99. Tzanakis IP, Papadaki AN, Wei M, Kagia S, Spadidakis VV, Kallivretakis NE, et al: Magnesium carbonate for phosphate control in patients on hemodialysis. A randomized controlled trial. Int Urol Nephrol 2008; 40: 193-201.
100. Agus ZS, Morad M: Modulation of cardiac ion channels by magnesium. Annu Rev Physiol 1991; 53: 299-307.
101. Covic A, Gusbeth-Tatomir P, Goldsmith DJ: Vascular calcification - a new window on the cardiovascular system: role of agents used to manipulate skeletal integrity. Semin Dial 2007; 20: 158-169.